ncRNA name
FOXC2-AS1
Specific or universal ncRNAs
Specific ncRNAs
Class
Long noncoding RNA
Biomarker
No
Biomarker application
Upstream regulatory factors
Not available
Downstream target
FOXC2
Cancer name
Osteosarcoma
Cancer site
Bone, Articular Cartilage
Treatment type
Chemotherapy
Drug
Doxorubicin
Impact of wild-type ncRNA on chemotherapy resistance
Up
Impact of knockdown of ncRNA on chemotherapy resistance
Impact of overexpression of ncRNA on chemotherapy resistance
ncRNA differential expression in
cancer
patients vs. healthy people
Not available
Number of patients
68
Male patients
50
Female patients
18
Age range and number
Not available
PMID
Description
Antisense lncRNA FOXC2-AS1 promotes doxorubicin resistance in osteosarcoma by increasing the expression of FOXC2.
Tissue resource
primary osteosarcoma tissues
human osteosarcoma cell lines MG63
human osteosarcoma cell lines SaoS2
human osteosarcoma cell lines HOS
Experiment
qRT-PCR,Western blot
Institute
the Shanghai Tenth Hospital
American Type Culture Collection
Country
China
USA
Continent
Asia
Amercia